baber/WOPTO huggingface dataset:
Patent NZ-226006-A (NZ)
Title: Pyridyl ethanolamine derivatives, animal feedstuffs and medicaments
Inventor: REIFFEN MANFRED
IPC: C07D213/61
Filed: 1988-08-31
Abstract: Pyridylethanolamines of the formula <IMAGE>  in which R denotes a carboxymethoxy, carbomethoxymethoxy, ethoxycarbonylmethoxy or 2-hydroxyethoxy group, their optical isomers, their diastereomers and their acid addition salts. The novel compounds of the above formula I, their optical isomers and their diastereomers and also their acid addition salts, in particular their physiologically tolerable acid addition salts with inorganic or organic acids, have useful pharmacological properties, namely an effect on the metabolism, preferably a hypoglycaemic and body fat-reducing effect, and also a lowering effect on the atherogenic beta -lipoproteins VLDL and LDL. The novel compounds of the above formula I can be prepared by processes which are known per se.
Patent NZ-231905-A (NZ)
Title: Substituted quinoxaline dione derivatives and pharmaceutical compositions
Inventor: HONORE TAGE
IPC: A61P25/20
Filed: 1989-12-20
Abstract: Heterocyclic dihydroxyquinoxaline compounds having the formula <CHEM>  wherein R<1> is hydroxy, alkoxy, aryloxy, aralkyloxy, cycloalkylalkoxy, cycloalkoxy, or acyloxy; R<5> and R<6> together form a further fused ring, which is substituted with hydrogen, halogen or CN, and R<7> and R<8> independently are hydrogen, NO2, halogen, CN, SO2NR min R min , SO2R min , CF3, or OR min , wherein R min  is hydrogen or C1-4-alkyl; or R<7> and R<8> together form a further fused ring, which is substituted with hydrogen, halogen or CN, and R<5> and R<6> independently are hydrogen, NO2, halogen, CN, SO2NR min R min , SO2R min , CF3, or OR min , wherein R min  is hydrogen or C1-4-alkyl. The invention also relates to a method of preparing the compounds, pharmaceutical compositions thereof, and their use. The compounds are useful in the treatment of indications caused by hyperactivity of the excitatory neurotransmitters, particularly the quisqualate receptors, and especially as neuroleptics.
Patent NZ-232287-A (NZ)
Title: Slow-release formulation of nifedipine comprising particles of water-soluble diluent coated with microcrystalline particles of nifedipine
Inventor: RHODES ALAN
IPC: A61K9/58
Filed: 1990-01-30
Abstract: A pharmaceutical composition which comprises particles of a finely divided pharmaceutically acceptable water soluble diluent coated with microcrystalline particles of nifedipine, the majority of which have a particle size of 100 micrometres or less in the presence of polyvinylpyrrolidone, the polyvinylpyrrolidone being present in an amount of from 10 to 90% by weight based on the weight of the nifedipine. The incorporation of polyvinylpyrrolidone in an amount of less than the amount of nifedipine significantly slows the dissolution of nifedipine from the finished solid dosage form.
Patent NZ-237479-A (NZ)
Title: Fluid dispensing nozzle: control valve and flow meter in removable module.
Inventor: SIMPSON DWAIN W
IPC: B67D7/42
Filed: 1991-03-19
Abstract: A fluid dispensing nozzle having electro-mechanical controls, an in-line, point-of-delivery flow meter and a data processing unit coupled to the flow meter. <IMAGE>   <IMAGE>
Patent NZ-240111-A (NZ)
Title: Injecting transponder near base of animal's ear
Inventor: BOLSCHER JEROEN JOZEF MARIA
IPC: A61M37/00
Filed: 1991-10-04
Abstract: Method for inserting of a transponder into a living being using a guide. Introduction of the transponder is effected near the base of the ear. The guide (needle) is inserted in a position into the skin being situated between the base of the ear flap and the part of the triangular piece of cartilage (the cartilago scutiformis) lying closest to the skin. <IMAGE>
Patent NZ-242951-A (NZ)
Title: Substituted benzimidazole derivatives,pharmaceutical compositions and uses
Inventor: AXELSSON OSKAR
IPC: A61P25/08
Filed: 1992-05-29
Abstract: The application discloses benzimidazole derivatives, pharmaceutical preparations comprised the compounds, their preparation and use in the treatment of disorders of the Central Nervous System such as ischemia, migraine, epilepsia, psychosis, Parkinsonism and depression.
Patent NZ-284432-A (NZ)
Title: Determining glucose concentration in a biological sample.
Inventor: ESSENPREIS MATTHIAS
IPC: A61B5/00
Filed: 1995-04-26
Abstract: PCT No. PCT/DE95/00573 Sec. 371 Date Oct. 10, 1995 Sec. 102(e) Date Oct. 10, 1995 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30368 PCT Pub. Date Nov. 16, 1995A method for the analytical determination of the glucose concentration in a biological sample. In a detection step, light is irradiated into the sample and the light emerging therefrom after interaction with the sample emerges therefrom is detected in order to measure a physical light property affected by said interaction. The glucose concentration is determined from this measurement in an evaluation step. To provide a method for determining glucose in reagent-free and non-invasive manner, the invention proposes that a portion of the light emitted by the light source be guided along a reference light path of defined optical path length to the photodetector, that the total measuring light path also has a defined optical length and that the measuring light path after it has traversed the sample is so combined with the reference light path that the measuring light and the reference light interfere with each other. The photodetector measures an interference signal used in the evaluation step to determine the glucose concentration.
Patent NZ-304650-A (NZ)
Title: Apparatus for selecting a planar article from a group and sending it to a desired location
Inventor: MONCRIEF FRANK
IPC: B65H3/08
Filed: 1996-03-13
Abstract: Apparatus, for selecting a planar article (partition 25) from a group of planar articles and delivering the article to a selected location, comprises means 26 for selecting the article from the group comprising a first vacuum assembly 65, a second vacuum assembly 68 and first means (frame 27) for moving assemblies 65 and 68 into engagement with article 25.  The first means 27 is operatively attached to assemblies 65 and 68 so that the assemblies are activated after the assemblies engage the article.  The first  means 27 also moves the assemblies away from the group of articles after the assemblies have engaged the article, whereby the article is removed from the group.  The apparatus includes means for deactivating assembly 68 after the article has been removed from the group and second means for moving assembly 65 and not assembly 68 in a second direction toward the selected location, the second means being operatively attached to assembly 65 so that assembly 65 is deactivated after the article has been moved in the second direction.
Patent NZ-500741-A (NZ)
Title: Inducible plant promoters selected from apple beta-galactosidase (ABG1) or 1-aminocyclopropane-1-carboxylate synthase (ACC synthase)
Inventor: GITTENS JOHN ROBERT
IPC: C12N15/82
Filed: 1998-04-03
Abstract: A recombinant polynucleotide comprising an inducible promoter activated in response to agents which are specific to ripening fruit, which inducible promoter is selected from either (i) the apple b-galatosidase (ABG1) promoter, or (ii) the apple 1-aminocyclopropane-1carboxylate synthase (ACC synthase) promoter. Also provided are host plant cells, plus methods of producing transgenic plants and fruit which incorporate antisense RNA capable of down-regulating genes involved in ripening or peptides or proteins for increasing resistance to fungal, insect, bacterial, viral, herbicidal, nematode, or arachnid. Such transgenic plants and fruit have storage and pest-resistance properties superior to non-transgenic varieties.
Patent NZ-502989-A (NZ)
Title: A cell structured lifting cushion
Inventor: MURPHY PAUL A
IPC: B66F3/35
Filed: 1998-08-27
Abstract: A lifting cushion includes a first and second layer and an inflatable envelope (64). The inflatable envelope (64) comprises two rectangular sheets (66,68) connected by a plurality of cell structures (72); the sheets (66,68) and the cell structures (72) being made of polyaramid cord. Each cell structure (72) consists of two opposed generally U-shaped half-cell members (74,76). The two half-cell members (74,76) of each cell structure (72) are threaded through adjacent slits (78) in the sheets (66,68) so that end arms (80,82) of the two half-cell members (74,76) extend towards each other to leave a small gap (84). The first layer is wrapped around the envelope (64), and the second layer is wrapped around the first layer at 90° to the direction of the first layer. The envelope (64) and the first and second layers are heated, compressed and hot vulcanized to secure these components to one another during manufacture of the lifting cushion.
Patent NZ-504844-A (NZ)
Title: Cyclosporin-containing microemulsion preconcentrate composition also comprising an oil, surfactant and a lipophilic solvent
Inventor: HONG CHUNG II
IPC: A61P37/06
Filed: 1998-10-16
Abstract: A cyclosporin containing microemulsion preconcentrate composition comprises: a) a cyclosporin as the active ingredient; b) an alkyl ester of polycarboxylic acid and/or carboxylic acid ester of polyols as a lipophilic solvent; c) an oil and d) a surfactant.
Patent NZ-506114-A (NZ)
Title: Dispensing closure for package containing a consumable beverage having a self sealing valve within a spout in the base of the closure and an overcap enclosing the spout in covering position
Inventor: LAMPE WILLIAM H
IPC: B65D47/20
Filed: 1999-01-21
Abstract: A sealing and dispensing closure for the outlet opening of a package, such as a flexible plastic bottle containing a consumable beverage. The closure comprises a closure base which is threaded onto the outlet opening of the bottle, and a removable overcap which is pivotally connected to the closure base. The closure base includes a spout having a self-sealing dispensing valve therein which is movable from a lowered closed position to a raised open position by an increased pressure in the bottle resulting from the squeezing of the bottle. The valve is positioned at a recessed location within the spout so as to preclude access to the valve by the consumer when the valve is lifted to its raised open position, and the overcap includes a post which seats in the upper end of the spout when the overcap is mounted on the closure base, and so as to form a hermetically sealed chamber above the valve which prevents the valve from lifting to its raised position in the event the bottle is inadvertently squeezed.
Patent NZ-510513-A (NZ)
Title: An infant simulator (doll) with neck tube to simulate pivoting of head of baby
Inventor: JURMAIN MARY M
IPC: G09B23/32
Filed: 1998-08-25
Abstract: The infant simulator comprises a doll (including a torso and a head), a curved neck tube, a neck tube retention system, a guide means for restricting movement of the head relative to the torso between a first position where the head is aligned with the torso and a second position where the head is tilted back relative to the torso.  The head is gravitationally biased toward the first position when the torso is in a generally vertical position and gravitationally biased toward the second position when the torso is in a generally horizontal position.  The neck tube retention system comprises: i) A first opening in the torso, including a first means for receiving a first end of the neck tube; ii) A second opening in the head, including a second means for receiving a second end of the neck tube; At least one of the first and second receiving means slidably engages the curved neck tube. The infant simulator system described above may also comprise a means effective for sensing positioning of the head at the second position, and a data recording means in communication with the head-position sensing means for recording a sensed positioning of the head proximate the second position as data. A method for training a person to properly support the head of a young infant comprises assigning the infant simulator described above to a person for an assignment period.
Patent NZ-512272-A (NZ)
Title: Pulmonary drug delivery
Inventor: MODI PANKAJ
IPC: A61K47/16
Filed: 1999-12-16
Abstract: An aerosol pharmaceutical formulation comprises a proteinic pharmaceutical agent, water, a phenol and a propellant. The phenol is phenol and/or methyl phenol in a concentration of from 1 to 10 wt./wt.% of the total formulation. The propellant is a C1-C2 dialkyl ether, butanes, fluorocarbon propellant, hydrogen-containing fluorocarbon propellant, chlorofluorocarbon propellant, or hydrogen- containing chlorofluorocarbon propellant, or mixtures thereof. Optionally, excipients selected from salts, antioxidants, coloring agents, flavouring agents, protease inhibitors, stabilizers, glycerin, polyglycerin, lysine, polylysine and mixtures thereof, may be present. Preferably, the formulation is administered buccally, using a metered dose dispenser.
Patent NZ-512983-A (NZ)
Title: Host cells that can present stable functional recombinant polypeptides that can carry out multistage enzyme reactions
Inventor: LUBITZ WERNER
IPC: C12P21/04
Filed: 2000-01-28
Abstract: Described are Gram-negative host cells that contain at least two functional recombinant polypeptides, at least one of which is bound to a substrate, preferably each one in different cell compartments, for example, the cytosol, the cytoplasmic membrane, the periplasm and the outer membrane.  Also described is a method for producing the host cells.  These host cells are especially useful as bioreactors for carrying out enzymatic reaction cascades for which a compartmentalisation of individual enzymes is advantageous or required.
Patent NZ-514328-A (NZ)
Title: Compositions and methods for the modification of gene expression
Inventor: PERERA RANJAN
IPC: A01H5/00
Filed: 2000-02-24
Abstract: Novel isolated plant super ubiquitin polynucleotide promoter sequences from Eucalyptus grandis and Pinus radiata, DNA constructs comprising such polynucleotides, methods for using such constructs in modulating the transcription of DNA sequences of interest and plants comprising such constructs.
Patent NZ-516946-A (NZ)
Title: Pulverulent hair bleaching composition containing an anionic or nonionic amphiphilic polymer modified with a fatty aicd, a polydecene and a peroxygenated salt
Inventor: LEGRAND FREDERIC
IPC: A61K8/31
Filed: 2002-01-31
Abstract: A  pulverulent  and  non  volatile  composition   for bleaching  human keratin fibres such as hair,  in  a  medium that is suitable for bleaching, comprises: at least one peroxygenated salt, at  least  one  nonionic and/or anionic amphiphilic  polymer comprising at least one fatty chain and at  least one polydecene of formula C10H[ (20n) + 2] with  n being 3 to 9, in an amount by weight of less than 10%.
Patent NZ-521625-A (NZ)
Title: Anti-angiogenic and anti-tumor properties of matin and other laminin domains
Inventor: KALLURI RAGHURAM
IPC: C07K16/18
Filed: 2001-03-28
Abstract: Isolated matin, wherein matin is an isolated protein of the G1 domain of the alpha chain of laminin, or a fragment, analog, derivative or mutant with angiogenic activity and their use in the manufacture of a medicament for treating disorders involving angiogenesis in a tissue.
Patent NZ-522859-A (NZ)
Title: Heuristic method of classifying objects using a vector space having multiple preclassified data clusters
Inventor: HITT BEN
IPC: G06K9/62
Filed: 2001-06-19
Abstract: A method of classifying Objects using a vector space having multiple preclassified data clusters comprises: a. inputting a data stream that describes the Object; b. abstracting the data stream to calculate an Object vector that characterizes the data stream; c. identifying the data cluster, if any, within which the Object vector rests; d. assigning to the Object the status of the identified data cluster or, if no cluster is identified, assigning to the Object the status of atypical.
Patent NZ-523470-A (NZ)
Title: Apparatus and method for reducing the risk of decubitus ulcers
Inventor: SMITH TOBY E
IPC: A61G12/00
Filed: 2001-06-08
Abstract: An apparatus for reducing the risk of occurrence of decubitus ulcers in a patient at rest on a support surface, wherein is provided a predetermined patient turn interval comprises: a) a patient location sensor (380) for determining at least approximately a location or orientation of the patient on the support surface; (b) a time circuit (320); (c) a microprocessor in electronic communication with the patient location sensor and the time circuit, the microprocessor at least for (c1) determining from the time circuit (320) and the patient location sensor (380) a time since the patient significantly changed location, and, (c2) initiating a signal indicative of a state of the patient depending on at least the patient location and the time since the patient last significantly changed position; and, (d) an alarm (395) in electronic communication with the microprocessor and responsive thereto, the alarm (395) at least for responding to the signal indicative of a state of the patient to produce an alarm signal (395).
Patent NZ-523888-A (NZ)
Title: Equiphase space time map determination of velocities of electrophoretic components
Inventor: SIDERIS DIMITROIS
IPC: G01P5/22
Filed: 2001-07-20
Abstract: The velocities of molecules migrating under electrophoretic influence are determined by generating an equiphase space-time map of equiphase points from each of a plurality of data sets representative of the signals detected at a plurality of spaced positions. The velocities of the molecules are determined by fitting the sets of equiphase points in the space-time map corresponding to the respective molecules.
Patent NZ-525338-A (NZ)
Title: Controllable texture sampling by providing input for specifying certain sampling parameters
Inventor: BOYD CHARLES N
IPC: G06T15/04
Filed: 2003-04-15
Abstract: A method for providing controllable texture sampling that comprises:- (a) Specifying at least one parameter of a sampling footprint utilized in connection with texture sampling of a texture map; and (b) Texture sampling the texture map in accordance with specified parameters of the sampling footprint. The parameter of step (a) can be DELTAu new and DELTAvnew. A form of anisotropic filtering - bilinear filtering performed multiple times along an angle è is used to control the texture sampling. When the textured polygon is at an oblique angle to the plane of the screen, the footprint corresponding to a screen pixel mapped onto the texture becomes an elongated shape such as an ellipse. The method provided supplements the current methods which compute the correct shape (by basing their computations on the relative geometry of the screen-pixel to polygon texel alignment) for the sampling footprint. The method provides a manual override of these automatic computations already performed and/or a modification to the result they generate enabling visual realism in real time 3-D graphics. The method provided replaces the size and orientation of the footprint by replacing the values DELTAu and DELTAv with DELTAunew and DELTAvnew . The values DELTAunew and DELTAvnew are used to define a replacement orientation thetanew and a replacement stepsize snew , allowing a developer to "manually" control the size and orientation of the footprint directly.
Patent NZ-527718-A (NZ)
Title: N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
Inventor: BRIDGES ALEXANDER JAMES
IPC: A61P35/00
Filed: 1999-09-23
Abstract: A method of treating cancer such as breast cancer or colon cancer, comprising administer to a non-human patient having cancer a therapeutically effective amount of the compound N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide; a method of treating or preventing restenosis in a non-human patient; a method of inhibiting the tyrosine phosphorylation of erbB3 in a non-human patient; a method of treating psoriasis, atherosclerosis or endometriosis in a non-human patient; and a method of inhibiting VEGF secretion in a non-human patient. (62) Divided out of 512189
Patent NZ-533535-A (NZ)
Title: Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
Inventor: BONNEVILLE GEORGE
IPC: C07F9/09
Filed: 2002-12-20
Abstract: A process is disclosed for making water-soluble phosphonooxymethyl ethers of hindered alcohol and phenol containing pharmaceuticals, such as camptothecin, propofol, etoposide, vitamin E and cyclosporin A. In particular, the process for preparing water-soluble phosphonooxymethyl derivatives comprises the steps (I) and (II) as shown herein, wherein R-OH represents an alcohol- or phenol-containing drug, n represents an integer of 1 or 2, R1 is hydrogen, an alkali metal ion, or a pharmaceutically acceptable cation, and R2 is hydrogen, an alkali metal ion, or a pharmaceutically acceptable cation.
Patent NZ-535044-A (NZ)
Title: Non-invasive method to determine the genetic sequence of foetal DNA from a sample from a pregnant female thereby detecting any alternation in gene sequence as compared with the wild type sequence
Inventor: DHALLAN RAVINDER
IPC: C12Q1/68
Filed: 2003-02-28
Abstract: Disclosed is a method useful for detection of genetic disorders. The method comprises determining the sequence of alleles of a locus of interest, and quantitating a ratio for the alleles at the locus of interest, wherein the ratio indicates the presence or absence of a chromosomal abnormality. Also disclosed are non-invasive methods for the detection of chromosomal abnormalities in a fetus. This is especially useful as a non-invasive method for determining the sequence of fetal DNA.
Patent NZ-537206-A (NZ)
Title: Aminoalcohol derivatives
Inventor: HATTORI KOUJI
IPC: A61K31/4406
Filed: 2003-06-25
Abstract: Disclosed is an aminoalcohol derivative of formula (I) wherein the substituents are as described in the specification. These compounds are used as selective beta-3 adrenergic receptor agonists for the treatment of pollakiuria or urinary incontinence.
Patent NZ-538649-A (NZ)
Title: Estimating strengths of wooden supports using gamma rays
Inventor: WALLACE GAVIN
IPC: G01M99/00
Filed: 2005-03-07
Abstract: Methods and apparatus for non-destructive testing of the strength of a wooden support 1, such as a power pole or building foundation, are disclosed. Gamma rays 23 are transmitted parallel to a neutral axis through a cross-section of the support and detected 24 at the opposite side of the support. The average density of wood in rows parallel to the neutral axis is calculated, from which the amount of unsound wood in each row can be determined. This allows an estimate of the strength of the wooden support to be made.